A Novel Combretastatin A-4 Derivative, AC-7700, Shows Marked Antitumor Activity against Advanced Solid Tumors and Orthotopically Transplanted Tumors

Search this Article

Author(s)

    • NIHEI Yukio
    • Pharmaceutical Research Laboratories, Ajinomoto Co., Inc
    • SUGA Yasuyo
    • Pharmaceutical Research Laboratories, Ajinomoto Co., Inc
    • OHISHI Kazuo
    • Pharmaceutical Research Laboratories, Ajinomoto Co., Inc
    • OKANO Akira
    • Pharmaceutical Research Laboratories, Ajinomoto Co., Inc
    • OHSUMI Koji
    • Pharmaceutical Research Laboratories, Ajinomoto Co., Inc
    • SAITO Sachiko
    • Department of Vascular Biology, Institute of Development, Aging and Cancer, Tohoku University
    • HORI Katsuyoshi
    • Department of Vascular Biology, Institute of Development, Aging and Cancer, Tohoku University
    • SATO Yasufumi
    • Department of Vascular Biology, Institute of Development, Aging and Cancer, Tohoku University
    • TSURUO Takashi
    • Laboratory of Biomedical Research, Institute of Molecular and Cellular Biosciences, University of Tokyo

Journal

  • Jpn J Cancer Res

    Jpn J Cancer Res 90(9), 1016-1025, 1999-09-30

References:  41

Cited by:  6

Codes

  • NII Article ID (NAID)
    10008092683
  • NII NACSIS-CAT ID (NCID)
    AA00690844
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    09105050
  • Data Source
    CJP  CJPref 
Page Top